Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
1.39 USD | -3.47% | +9.45% | +104.41% |
Apr. 18 | Imunon Receives FDA Approval to Start Phase 1 Trial of COVID-19 Booster Vaccine | MT |
Apr. 18 | Imunon Shares Rise 8% After Clearance to Start Phase 1 Trial for Covid-19 Booster Vaccine | DJ |
Financials (USD)
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 13.54M |
---|---|---|---|---|---|
Net income 2024 * | -23M | Net income 2025 * | -26M | EV / Sales 2024 * | - |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-0.64
x | P/E ratio 2025 * |
-0.84
x | Employees | 33 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 98.85% |
Latest transcript on Imunon, Inc.
1 day | -3.47% | ||
1 week | +9.45% | ||
Current month | -15.24% | ||
1 month | -27.98% | ||
3 months | +143.86% | ||
6 months | +39.00% | ||
Current year | +104.41% |
Managers | Title | Age | Since |
---|---|---|---|
Michael Tardugno
CHM | Chairman | 73 | 07-01-02 |
Jeffrey Church
DFI | Director of Finance/CFO | 67 | 10-07-05 |
Sebastien Hazard
CTO | Chief Tech/Sci/R&D Officer | 53 | Dec. 10 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 56 | 21-06-07 | |
Frederick Fritz
BRD | Director/Board Member | 73 | 11-07-07 |
James Dentzer
BRD | Director/Board Member | 57 | 22-10-02 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-29 | 1.39 | -3.47% | 43 731 |
24-04-26 | 1.44 | 0.00% | 49,331 |
24-04-25 | 1.44 | +10.77% | 69,402 |
24-04-24 | 1.3 | -2.26% | 32,477 |
24-04-23 | 1.33 | +4.72% | 51,141 |
Delayed Quote Nasdaq, April 29, 2024 at 01:47 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+104.41% | 13.54M | |
-2.56% | 103B | |
+1.76% | 95.28B | |
+1.46% | 22.15B | |
-15.71% | 21.02B | |
-8.58% | 18.15B | |
-38.74% | 16.73B | |
-12.71% | 16.05B | |
+5.65% | 13.68B | |
+34.44% | 12.17B |
- Stock Market
- Equities
- IMNN Stock